Easy Branches allows you to share your guest post within our network in any countries of the world to reach Global customers start sharing your stories today!

Easy Branches

34/17 Moo 3 Chao fah west Road, Phuket, Thailand, Phuket

Call: 076 367 766

info@easybranches.com

Financial Personal

PharmAla to supply Johns Hopkins Medicine for Clinical Trial

TORONTO, Sept. 11, 2024 (GLOBE NEWSWIRE) — PharmAla Biotech Holdings Inc. (“PharmAla” or the “Company”) (CSE: MDMA) (OTC:MDXXF), a biotechnology company focused on the research, development, and manufacturing of LaNeo™ MDMA and novel derivative

By: financialpost.com

Sep 11 2024
0
0 Views

For more information, please contact:
Nicholas Kadysh
Chief Executive Officer
PharmAla Biotech Holdings Inc.
Email: press@PharmAla.ca
Phone: 1-855-444-6362
Website: www.PharmAla.ca Read More

Related

Forsys opens bulk sampling box cut at Valencia with Inaugural blast

Anaplan Selects NetApp to Unify Data Storage to Accelerate AI

Reinforced Earth Company Ltd. Partners with Trumer Schutzbauten Americas Ltd. to Strengthen Rockfall and Slope Stabilization Solutions in Quebec

Trump Trades Are Being Dialed Back Even More After the US Debate

PTX Metals Announces Appointment of Frederico Marques to the Board of Directors

Toronto welcomes The Oulim: Unique exhibition fusing Korean culture and cutting-edge technology begins!

Trump Media Shares Slide After Debate as Lockup Expiry Looms

PharmAla to supply Johns Hopkins Medicine for Clinical Trial

Blackline Safety Reports Record Quarterly Revenue of $33.7M up 36% Year-Over-Year and Positive EBITDA in Fiscal Third Quarter

Aurora Spine to Host ZOOM Call with Alpha Wolf Trading CEO Tim Weintraut

Probe Gold Advances Permitting for Novador Project

Silicon-Anode Batteries Outperform Graphite by 39% With 98% Capacity Retention, After 150 Cycles

Share this page

Guest Posts by Easy Branches

anchor links ads by Easy Branches

Next

Forsys opens bulk sampling box cut at Valencia with Inaugural blast